Media coverage
1Media coverage
Title VBL Therapeutics to Present Complete Phase 2 Data on VB111 in Combination With Bevacizumab in Recurrent GBM at the European Cancer Conference Media name/outlet BioPortfolio Country United Kingdom Date 9/17/15 Persons Andrew Brenner